Drug injection device

The patch-type drug injection device addresses instability issues by centralizing the injection assembly and using an electroosmotic pump, ensuring stable and accurate insulin delivery for diabetic patients, even during movement or shocks.

WO2024237547A1PCT designated stage expired Publication Date: 2024-11-21CAREMEDI CO LTD +1
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2024/006149
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-16
Filing Date
2024-05-08
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

Insulin injectors used by diabetic patients face instability due to movement or external shocks, leading to dislodgment of the insertion tube, which affects accurate and continuous drug delivery.

Method used

A patch-type drug injection device with a central injection assembly, surrounded by a drug storage unit, pump assembly, and circuit unit, featuring an electroosmotic pump and a silicone cap to secure the insertion tube, ensuring stability during user movement or external shocks.

Benefits of technology

The device maintains the insertion tube's stability and accuracy of drug delivery, allowing continuous operation for 24 hours without dislodgment, enhancing user convenience and miniaturization for daily use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2024006149_21112024_PF_FP_ABST
    Figure KR2024006149_21112024_PF_FP_ABST
Patent Text Reader

Abstract

A patch-type drug injection pump according to the present invention comprises: a housing including a cover part and a contact surface; and components mounted in a mounting space between the cover part and the contact surface, wherein the components comprise: a drug storage unit for storing a drug to be injected; a pump assembly which is driven to send the drug of the drug storage unit to an injection target side; a circuit unit in which electronic components necessary for driving and controlling a pump are mounted; and an injection assembly in which an insertion pipe inserted into an injection target is mounted, the injection assembly is disposed in a central region of the mounting space, and the drug storage unit, the pump assembly, and the circuit unit are disposed to surround the injection assembly around the injection assembly.
Need to check novelty before this filing date? Find Prior Art

Description

drug injection device

[0001] The present invention relates to a patch-type drug injection device.

[0002] Depending on the type, purpose, and method of treatment, medications can be administered orally, subcutaneously, or intravenously. Drug infusion devices utilizing drug pumps can automatically inject medication into the body at the desired rate and dose at the required time. Therefore, drug infusion devices utilizing drug pumps can be utilized in a variety of ways, not just in hospitals or patients' daily lives.

[0003] An insulin pump, commonly called an insulin injector, is a medical device that acts like a pancreas to control blood sugar levels by supplying insulin from outside the body at a set time precisely for diabetic patients who do not secrete insulin or secrete only a small amount.

[0004] These insulin pumps are used by patients with insulin-dependent diabetes, and can deliver medication continuously 24 hours a day while attached to the patient. Because insulin injectors require patients to administer medication periodically over long periods of time, active technology development is underway to miniaturize and automate insulin injectors for greater user convenience.

[0005] Insulin injectors are generally attached to the user's body for a specified period of time, but the insertion tube inserted into the user may come out due to the user's movement or external impact.

[0006] Therefore, a device is required that can stably inject an accurate amount of medication to a patient by maintaining the injected insertion tube even when the user moves or is subjected to external impact.

[0007] In order to solve the above-mentioned problem, the present invention has as a technical object the provision of a drug injection device in which an injection assembly for injecting a drug is disposed in the central portion.

[0008] However, the technical tasks that this embodiment seeks to accomplish are not limited to the technical tasks described above, and other technical tasks may exist.

[0009] As a technical means for solving the above-described technical problem, a drug injection device according to one embodiment of the present invention comprises: a housing including a cover part and a contact surface; and components mounted in a mounting space between the cover part and the contact surface, wherein the components include: a drug storage part for storing a drug to be injected; a pump assembly driven to send the drug from the drug storage part to an injection target; a circuit part on which electronic components required for driving and controlling the pump are mounted; and an injection assembly equipped with an insertion tube to be inserted into an injection target, wherein the injection assembly is disposed in a central region of the mounting space, and the drug storage part, the pump assembly, and the circuit part are disposed to surround the injection assembly with the injection assembly as the center.

[0010] According to the problem solving means of the present invention described above, by arranging the injection assembly in the central portion, even if a part of the housing moves due to the user's movement or external impact, the inserted tube can be stably maintained in the injected state for the user.

[0011] FIG. 1 is a front perspective view of a drug injection device according to one embodiment of the present invention.

[0012] FIG. 2 is a rear perspective view of a drug injection device according to one embodiment of the present invention.

[0013] Figure 3 is an exploded perspective view of the housing illustrated in Figure 1.

[0014] Figure 4 is a plan view of the inside of the housing shown in Figure 1.

[0015] Figure 5 is a plan view of the drug storage unit illustrated in Figure 4.

[0016] Figure 6 is a perspective view of the pump assembly illustrated in Figure 4.

[0017] Figure 7 is a cross-sectional view of the port connector illustrated in Figure 6.

[0018] Figure 8 is a block diagram schematically showing the configuration of the electroosmotic pump illustrated in Figure 6.

[0019] Fig. 9 is a block diagram schematically showing the configuration of the driving unit illustrated in Fig. 8.

[0020] Fig. 10 is an exemplary diagram schematically showing the operation of the driving unit illustrated in Fig. 9.

[0021] Figure 11 is a perspective view of the injection assembly illustrated in Figure 4.

[0022] Figure 12 is an enlarged view of point A in Figure 2.

[0023] Figure 13 is a perspective view of the injection assembly combined with Figure 12.

[0024] FIG. 14 and FIG. 15 are rear perspective views of a drug injection device according to one embodiment of the present invention.

[0025] Hereinafter, the present invention will be described in detail with reference to the attached drawings. However, the present invention can be implemented in various different forms and is not limited to the embodiments described herein. In addition, the attached drawings are only intended to facilitate easy understanding of the embodiments disclosed in the present specification, and the technical ideas disclosed in the present specification are not limited by the attached drawings. In order to clearly explain the present invention in the drawings, parts that are not related to the description are omitted, and the size, shape, and shape of each component shown in the drawings can be variously modified. The same / similar drawing reference numerals are assigned to the same / similar parts throughout the specification.

[0026] The suffixes "module" and "part" used in the following description for components are assigned or used interchangeably solely for the convenience of writing the specification, and do not in themselves have distinct meanings or roles. Furthermore, in describing the embodiments disclosed herein, detailed descriptions of related known technologies have been omitted if they are deemed to obscure the gist of the embodiments disclosed herein.

[0027] Throughout the specification, when a part is said to be "connected (connected, in contact with, or coupled)" to another part, this includes not only cases where it is "directly connected (connected, in contact with, or coupled)" but also cases where it is "indirectly connected (connected, in contact with, or coupled)" with another member in between. Furthermore, when a part is said to "include (have or provide)" a certain component, this does not mean that it excludes other components, but rather that it may "include (have or provide)" other components, unless otherwise specifically stated.

[0028] As used herein, ordinal terms such as "first," "second," etc., are used solely to distinguish one component from another and do not limit the order or relationship between the components. For example, the first component of the present invention may be referred to as the "second component," and similarly, the second component may also be referred to as the "first component."

[0029] FIG. 1 is a front perspective view of a drug injection device according to an embodiment of the present invention, FIG. 2 is a rear perspective view of a drug injection device according to an embodiment of the present invention, FIG. 3 is an exploded perspective view of the housing illustrated in FIG. 1, and FIG. 4 is a plan view of the inside of the housing illustrated in FIG. 1.

[0030] Referring to FIGS. 1 to 4, a patch-type drug injection device (100) according to one embodiment of the present invention is described. The patch-type drug injection device (100) includes a housing (110) and components arranged inside the housing (110).

[0031] The housing (110) includes a cover portion (111) and a contact surface (112), and a mounting space is formed between the cover portion (111) and the contact surface (112). The cover portion (111) has rounded corners, so that the patch-type drug injection device (100) can be continuously attached to the injection target without a foreign body sensation. The contact surface (112) is configured to be attached to the injection target, and an outlet (112a) for withdrawing the insertion tube to the outside is formed. Here, a silicone cap can be combined with the outlet (112a), so that the insertion tube inserted into the injection target can be fixed.

[0032] The mounting space is divided into a central region (113) and first to third regions (114, 115, 116), and the first to third regions (114, 115, 116) are formed in a shape that surrounds the central region (113). In particular, the mounting space within the housing (110) is divided into first to third regions (114, 115, 116) that extend in a direction perpendicular to the insertion direction of the insertion tube, and the central region (113). Then, major components are combined in each region. In a typical case, the PCB circuit part is first arranged over the entire or most of the plane of the device, and then the drug storage part or pump, etc. are arranged on top of it, so there is a problem that the thickness of the device is formed thick. However, in order to make the patch-type drug injection device (100) of the present invention thin, the area where each component overlaps with each other is minimized.

[0033] In addition, the housing (110) may further include a case frame (117) that fixes components placed in the mounting space, and the case frame (117) may divide the central region (113) and the first to third regions (114, 115, 116). In addition, the case frame (117) is coupled between the cover portion (111) and the contact surface (112).

[0034] The components include a drug storage unit (120), a pump assembly (130), a circuit unit (140), and an injection assembly (150), and can be arranged in the central region (113) and the first to third regions (114, 115, 116) described above. For example, the drug storage unit (120) can be arranged in the first region (114), the pump assembly (130) in the second region (115), the circuit unit (140) in the third region (116), and the injection assembly (150) in the central region (113), such that the drug storage unit (120), the pump assembly (130), and the circuit unit (140) can be arranged in a manner that surrounds the injection assembly (150).

[0035] In this way, the injection assembly (150) including the insertion tube is positioned in the central region (113) so that the patch-type drug injection device (100) can remain connected to the user without the insertion tube coming off even when there is a change such as shaking due to the user's movement.

[0036] Next, the drug storage unit (120), pump assembly (130), circuit unit (140), and injection assembly (150) will be described in detail.

[0037] Fig. 5 is a plan view of the drug storage unit illustrated in Fig. 4. Referring to Fig. 5, the drug storage unit (120) stores a drug to be injected, and its thickness varies depending on the amount of drug to be injected. The drug storage unit (120) may be provided as a flat pouch bag made of a polymer material. A closing unit (121) may be formed around the drug storage unit (120) by joining both sides of the drug storage unit (120) to a predetermined width. The closing unit (121) may limit the drug storage unit (120) from expanding toward the drug periphery.

[0038] The drug storage unit (120) can be composed of a polymer film, etc., and the inside and outside of the drug storage unit (120) are made of materials having different melting temperatures, and the melting temperature of the inside material is lower than the melting temperature of the outside material. The drug storage unit (120) is made by applying heat to a predetermined temperature at which the inside material melts to form a closing unit (121). When heat is applied to the side of the closing unit (121), the inside materials are attached to each other and finished, and when the lower side is folded into a W shape and heat is applied, the inside materials are attached to each other and the outside materials are not attached to each other, so the patch-type drug injection device (100) is finished in a wrinkled shape. Unlike conventional technologies, since the drug storage unit (120) is formed thinly using a flexible material, the patch-type drug injection device (100) can be implemented to be thinner and lighter.

[0039] Figure 6 is a plan view of the pump assembly illustrated in Figure 4, and Figure 7 is a cross-sectional view of the port connector illustrated in Figure 6.

[0040] Referring to Fig. 6, the pump assembly (130) draws in a drug from the drug storage unit (120) and delivers the drug to the injection assembly (150). The pump assembly (130) includes an electroosmotic pump (131) and a port connector (132). The electroosmotic pump (131) is an electrochemically driven pump and will be described in detail later. Referring to Fig. 7, the port connector (132) has an inflow path (132a) formed therein through which a drug is introduced from the drug storage unit (120) into the electroosmotic pump (131) and a discharge path (132b) formed through which a drug is discharged from the electroosmotic pump (131) to the injection assembly (150).

[0041] Next, the electroosmotic pump (131) will be described in detail with reference to FIGS. 8 to 10.

[0042] Figure 8 is a block diagram schematically showing the configuration of the electroosmotic pump (131) illustrated in Figure 6.

[0043] Referring to FIG. 8, the electroosmotic pump (131) will be described in detail. The electroosmotic pump (131) includes a driving unit (133) and a chamber (134). The driving unit (133) is electrochemically driven by a control signal to generate positive and negative pressures, thereby drawing in a drug from the drug storage unit (120), storing it in the chamber (134), and discharging the drug stored in the chamber (134) to the injection assembly (150). The chamber (134) receives the drug drawn from the drug storage unit (120) according to the pressure of the driving unit (133). Here, the drug is a drug that must be injected into a specific patient, and an example of this is insulin that is injected into a diabetic patient.

[0044] Fig. 9 is a block diagram schematically showing the configuration of the driving unit illustrated in Fig. 8, and Fig. 10 is an exemplary diagram schematically showing the operation of the driving unit illustrated in Fig. 9.

[0045] Referring to FIGS. 9 and 10, the driving unit (133) is a pump that uses the movement of fluid by the electroosmotic phenomenon that occurs when voltage or current is applied using electrodes at both ends of the pumping unit (membrane, 133a). The driving unit (133) may include a power source (133d) that applies voltage or current to the membrane (133a) and the first electrode (133b) and the second electrode (133c) arranged on both sides of the membrane (133a), a first diaphragm (133e) for moving the fluid, and a second diaphragm (133f). Each diaphragm (133e, 133f) is provided on one side and the other side of the pumping unit (133a) and changes shape by the movement of the pumping solution as positive pressure and negative pressure are alternately generated. For example, the first diaphragm (133e) and the second diaphragm (133f) transfer the negative pressure and positive pressure generated by the operation of the pumping unit (133a) to the fluid to be transported. More specifically, when negative pressure is generated, at least a part of the first diaphragm (133e) and the second diaphragm (133f) moves backward (when moving in the ① direction), and the fluid to be transported is sucked into the chamber (134). Conversely, when positive pressure is generated, at least a part of the first diaphragm (133e) and the second diaphragm (133f) moves forward (when moving in the ② direction), and the fluid to be transported is discharged from the chamber (134).

[0046] The materials used for the membrane (133a) are generally silica, glass, etc., and when these are immersed in an aqueous solution, their surfaces become negatively charged. The membrane (133a) has numerous paths through which fluids can pass, and when one of these is enlarged, the surface of the fluid passage with a negative charge (bound anion) can be in a state where the charge is balanced by cations (mobile cations) with a movable (+) charge. In this state, when a (+) voltage is applied to the first electrode (133b) and a (-) voltage is applied to the second electrode (133c), a negative pressure is generated, and the fluid inside the driving unit (133) moves in the ① direction due to this negative pressure. At this time, the drug is inhaled through the inhalation path (136) and flows into the chamber (134) through the inhalation valve (135). At this time, the discharge valve (137) is closed so that negative pressure is not transmitted to the discharge path (138). Conversely, when a (-) voltage is applied to the first electrode (133b) and a (+) voltage is applied to the second electrode (133c), a positive pressure in the opposite direction is generated by a reversible electrochemical reaction. The fluid inside the driving unit (133) moves in the ② direction due to this positive pressure. At this time, the drug stored in the chamber (134) is injected into the subject through the discharge valve (137) and the discharge path (138). At this time, the suction valve (135) is closed so that positive pressure is not transmitted to the suction path (136).

[0047] This phenomenon is called electroosmosis, and a pump utilizing this principle is an electroosmotic pump (131). In the present invention, since an electroosmotic pump (131) is used as a driving means in a patch-type drug injection device (100), the driving means can be manufactured thinner than in other technologies using electric motors, etc. Accordingly, the overall thickness of the patch-type drug injection device (100) can be manufactured thinner, allowing for more stable bonding to the skin.

[0048] Referring again to FIG. 4, the circuit unit (140) may include electronic components necessary for driving and controlling the pump assembly (130) and may include a battery (141) for supplying power. In addition, the injection assembly (150) may include an insertion tube to inject the drug discharged from the pump assembly (130) into the injection target.

[0049] Fig. 11 is a perspective view of the injection assembly illustrated in Fig. 4. Referring to Fig. 11, the injection assembly (150) will be described. The injection assembly (150) may be composed of only a needle (151) as an insertion tube, or may be composed of a needle (151) and a cannula (152).

[0050] FIG. 11 is an embodiment showing a case where the insertion tube is composed of a needle (151) and a cannula (152), and the injection assembly (150) may include a needle pusher (153) and a return spring (154) to which the needle (151) and the cannula (152) are coupled.

[0051] The needle (151) is coupled to the discharge path (132b) of the port connector (132) and extends from the discharge path (132b) toward the discharge port (112a) of the contact surface (112), and the cannula (152) is positioned toward the discharge port (112a) with the needle (151) inserted therein. The needle pusher (153) is configured such that a portion of the needle (151) is fixed and moves by an external force to insert the needle (151) and the cannula (152) into the injection target. The return spring (154) contracts and relaxes along the direction of travel of the needle pusher (153) to return the needle pusher (153) to its original position.

[0052] Additionally, the injection assembly (150) may further include a guide portion. The guide portion guides the movement of the needle pusher (153) by inserting a portion of the needle pusher (153). Here, the guide portion may be formed on the case frame (117).

[0053] Fig. 12 is an enlarged view of point A of Fig. 3. Referring to Fig. 12, the guide portion (155) is formed in a cylindrical shape extending along the insertion direction of the needle (151), and a guide groove (155a) is formed inside, extending in the insertion direction of the needle (151), into which a portion of the needle pusher (153) is inserted.

[0054] Fig. 13 is a perspective view showing the shape in which the injection assembly (150) is coupled to the case frame (117), and a part of the needle pusher (153) is inserted into and coupled to the guide groove (155a) of the guide portion (155), and the injection assembly (150) moves along the guide portion (155).

[0055] Next, the additional configuration of the patch-type drug injection device (100) will be described with reference to FIGS. 1 and 2.

[0056] Referring to Fig. 1, a cover portion (111) of a housing (110) has a shooting hole (111a) formed in an area corresponding to an area where an injection assembly (150) is placed. The shooting hole (111a) is a hole (111a) into which a shooting member of a shooting device (not shown) that presses a needle pusher (153) is inserted so that a needle (151) and a cannula (152) can be inserted into an injection target. After the shooting member penetrates the shooting hole (111a), it collides with the needle (151) and the needle pusher (153), and the needle (151) and the needle pusher (153) move toward the discharge port (112a) by the force of the shooting member pushing the needle (151) and the needle pusher (153).

[0057] Referring to Fig. 2, a drug injection hole (112b) and an air vent hole (112c) are formed in the contact surface (112) of the housing (110). The drug injection hole (112b) is a hole for supplying a drug to be stored in the drug storage unit (120) from the outside, and the air vent hole (112c) is a hole for removing the pressure difference between the inside and the outside of the housing (110). The drug injection hole (112b) is formed at a position corresponding to a drug injection path (not shown) formed in the port connector (132), and the drug can be injected through the drug injection hole (112b) and the drug injection path using a syringe or the like.

[0058] In addition, the patch-type drug injection device (100) may include a sound output device (not shown) inside the housing (110) to provide a notification for a specific situation. In addition, the circuit unit (140) may include a sound output circuit unit that can stop the operation of the sound output device (not shown), and a buzzer stop hole (112d) that provides a passage that can disconnect the sound output circuit unit of the circuit unit (140) may be formed in the contact surface (112). Here, a silicone cap may be coupled to the discharge port (112a) and the drug injection hole (112b), and an air vent sticker may be attached to the air vent hole (112c) and the buzzer stop hole (112d).

[0059] Additionally, referring to FIGS. 14 and 15, the contact surface (112) of the housing (110) includes an adhesive sheet (112e) so as to be attached to an injection target, and the adhesive sheet (112e) is formed to be larger than the area of ​​the contact surface (112) and extends to the perimeter of the contact surface (112). In addition, a release paper (112f) is attached to the adhesive sheet (112e). FIG. 14 shows a state in which the release paper (112f) is attached, and when the release paper (112f) is removed, the adhesive sheet (112e) is exposed as shown in FIG. 15. In addition, a pre-processed cut portion is formed in the center of the release paper (112f), so that the release paper (112f) can be easily removed before being attached to the injection target.

[0060] Unlike other conventional drug injection devices, the patch-type drug injection device (100) of the present invention is manufactured to have a wide area and a thin thickness, thereby improving the stability of connection with the user.

[0061] Those skilled in the art will appreciate that, based on the above description, the present invention can be readily modified into other specific forms without altering the technical spirit or essential characteristics thereof. Therefore, the embodiments described above should be understood as illustrative in all respects and not restrictive. The scope of the present invention is defined by the following claims, and all changes or modifications derived from the meaning and scope of the claims and their equivalents should be construed as being included within the scope of the present invention.

[0062] The scope of the present invention is indicated by the claims described below rather than the detailed description above, and all changes or modifications derived from the meaning and scope of the claims and their equivalent concepts should be interpreted as being included in the scope of the present invention.

Claims

1. In a patch-type drug injection device, a housing including a cover portion and a contact surface; and Including components mounted in the mounting space between the above cover and the contact surface, The above parts are, A drug storage unit that stores the drug to be injected; A pump assembly driven to send the drug from the above drug storage unit to the injection target side; A circuit section in which electronic components necessary for driving and controlling the pump are mounted; and An injection assembly comprising an insertion tube for insertion into an injection target, The above injection assembly, It is placed in the central area of ​​the above-mentioned installation space, A drug injection device, wherein the drug storage unit, the pump assembly, and the circuit unit are arranged to surround the injection assembly with the injection assembly as the center.

2. In paragraph 1, The above installation space is, It is divided into first to third regions in a form that extends in a direction perpendicular to the insertion direction of the above insertion tube and surrounds the central region, A drug injection device, wherein the drug storage unit, the pump assembly, and the circuit unit are respectively arranged in the first to third regions.

3. In paragraph 1, A drug injection device further comprising an adhesive sheet mounted on the contact surface.

4. In paragraph 3, The above adhesive sheet, A drug injection device formed to be larger than the area of ​​the above contact surface and extending to the perimeter of the above contact surface.

5. In paragraph 3, Further comprising a release paper protecting the above adhesive sheet, The above heteromorphism is, A drug injection device having a pre-processed incision formed in the central portion.

6. In paragraph 1, The above housing, A drug injection device further comprising a case frame arranged in the above-mentioned mounting space to which the components are fixed.

7. In paragraph 6, The above case frame, A drug injection device, comprising a guide portion extending along the insertion direction of the insertion tube inserted into the central portion of the case frame and guiding the movement of the insertion tube.

8. In paragraph 7, A drug injection device wherein the above guide portion is formed in a cylindrical shape.

9. In paragraph 1, The above cover part, A drug injection device in which a shooting hole is formed in an area corresponding to the area where the above insertion tube is placed.

10. In paragraph 1, The above cover part, A drug injection device with rounded corners.

11. In paragraph 1, The above pump assembly, A drug injection device that sucks a drug from the drug storage unit and delivers the drug to the injection assembly side.

12. In paragraph 11, The above pump assembly, Electrochemically driven electroosmotic pump; and A drug injection device comprising a port connector providing an inflow path through which a drug is introduced from the drug storage unit to the electroosmotic pump and a discharge path through which a drug is discharged from the electroosmotic pump to the injection assembly.

13. In paragraph 1, A drug injection device, wherein the above drug storage unit is formed of a pouch bag made of polymer material.

14. In paragraph 13, The above pouch bag is a drug injection device formed into a flat shape.

15. In paragraph 13, A drug injection device, wherein a closing portion is formed around the circumference of the above pouch bag to limit expansion toward the circumference.

16. In paragraph 1, A drug injection device, wherein the above insertion tube is a needle.

17. In paragraph 1, The above insertion tube is, Needle; and A drug injection device comprising a cannula into which the needle is inserted and positioned toward the injection target side.

18. In paragraph 1, A drug injection device further comprising a sound output device coupled to the inner side of the cover portion.

19. In paragraph 1, The above contact surface is, A drug injection device having a drug injection hole formed therein for supplying a drug to be stored in the drug storage unit from the outside.

20. In paragraph 1, The above contact surface is, A drug injection device having an outlet formed therein for withdrawing the insertion tube from the injection assembly to the outside of the contact surface.

21. In paragraph 1, The above contact surface is, A drug injection device having an air vent hole formed therein to remove the pressure difference between the inside and outside of the housing.

22. In paragraph 1, The above circuit part, Includes a sound output circuit capable of stopping the operation of a sound output device built into the housing, The above contact surface is, A drug injection device having a buzzer stop hole formed therein, which provides a passageway accessible from the outside to the sound output circuit.

Citation Information

Patent Citations

  • Patch type drug injector

    KR1020140101255A

  • Medical fluid delivery device

    KR1020180028232A

  • Medical liquid dispensing device

    KR1020180042737A

  • Battery Discharge Apparatus And Discharging Method Thereof

    KR1020230129937A

  • E-Cigarette

    KR1020240048692A